Novartis Investigative Site

Wittenberg 06886

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease and Lipoprotein(a), Heart Failure With Preserved Ejection Fraction

Studies at this site

• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction — Completed